Melanotan II

Melanotan II is a seven-residue analogue of alpha-melanocyte-stimulating hormone, cyclised through an amide bond between the side chain carboxyl of an aspartate and the side chain amine of a lysine. That bridge, formed between side chains rather than through the backbone or through a disulfide, is a lactam, and it is chemically far more stable than the disulfide bridges that close many natural cyclic peptides.

The ring constrains the His-D-Phe-Arg-Trp pharmacophore into a fixed conformation, which is what produces both the potency and the loss of discrimination between receptor subtypes. It is described in the literature as a non-selective melanocortin agonist, with reported activity at MC1R, MC3R, MC4R and MC5R, and that breadth is the substantive difference from Melanotan I rather than a difference of degree.

Cyclic AMP accumulation across a panel of transfected cell lines expressing individual melanocortin receptor subtypes is the core dataset, since the defining characteristic of this compound is its profile across the family rather than its potency at any one receptor. Radioligand competition assays supply binding affinities alongside the functional numbers.

Melanogenesis endpoints in cultured pigment cells and the classical amphibian melanophore assays provide the MC1R-linked readouts. Rodent work in the literature centres on central melanocortin signalling, where MC3R and MC4R are the expressed subtypes, and this is the portion of the evidence base where a non-selective ligand behaves quite differently from an MC1R-preferring one.

The critical analytical question for any cyclic peptide is whether the ring actually closed. Lactam formation eliminates one molecule of water, so the cyclised product is exactly 18 daltons lighter than its linear precursor, and mass spectrometry separates the two without ambiguity. A lot report that confirms mass is therefore confirming cyclisation, provided the expected mass quoted is the cyclic one.

Two further impurity classes accompany a cyclisation step. Cyclodimers form when the reaction couples two chains instead of closing one, and appear at approximately double the mass. Incompletely cyclised material can also carry a protecting group, giving another distinct mass. Reversed-phase HPLC resolves these because the compact cyclic conformation is chromatographically distinct from the extended linear form, which typically elutes later.